Stockscreener 앱 받기
3.9299
4.11%
-0.2001
전일 마감가:
$4.13
열려 있는:
$4.12
하루 거래량:
2.85M
Relative Volume:
0.63
시가총액:
$966.32M
수익:
$251.85M
순이익/손실:
$-72.58M
주가수익비율:
-12.54
EPS:
-0.3134
순현금흐름:
$-63.80M
1주 성능:
-25.98%
1개월 성능:
-12.96%
6개월 성능:
-30.77%
1년 성능:
-54.59%
1일 변동 폭
$3.89
$4.18
1주일 범위
$3.89
$5.645
52주 변동 폭
$3.89
$9.33
Ardelyx Inc Stock (ARDX) Company Profile
명칭
Ardelyx Inc
전화
510-745-7047
주소
34175 ARDENWOOD BLVD., FREMONT, CA
ARDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
3.94 | 966.32M | 251.85M | -72.58M | -63.80M | -0.3134 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.02 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
608.08 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
655.29 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.08 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
253.12 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-07 | 재개 | Ladenburg Thalmann | Buy |
| 2025-03-04 | 개시 | BTIG Research | Buy |
| 2024-11-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | 개시 | Leerink Partners | Outperform |
| 2023-12-18 | 개시 | Raymond James | Strong Buy |
| 2023-09-07 | 개시 | H.C. Wainwright | Buy |
| 2023-08-25 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-11-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-07-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-03-23 | 개시 | Wedbush | Outperform |
| 2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-20 | 재개 | Citigroup | Buy |
| 2020-02-18 | 재개 | Jefferies | Buy |
| 2020-02-12 | 개시 | Citigroup | Buy |
| 2020-02-10 | 개시 | Cowen | Outperform |
| 2019-04-08 | 개시 | Piper Jaffray | Overweight |
| 2018-08-24 | 개시 | Jefferies | Buy |
| 2018-03-19 | 재개 | Leerink Partners | Outperform |
| 2017-11-29 | 재확인 | Citigroup | Buy |
| 2017-11-22 | 재확인 | Ladenburg Thalmann | Buy |
| 2017-10-17 | 재개 | Leerink Partners | Outperform |
| 2016-03-31 | 개시 | Ladenburg Thalmann | Buy |
| 2016-03-09 | 개시 | Cantor Fitzgerald | Buy |
| 2016-03-03 | 개시 | Citigroup | Buy |
모두보기
Ardelyx Inc 주식(ARDX)의 최신 뉴스
Ardelyx downgraded at Raymond James after Q1 sales miss - MSN
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2025 Earnings Call Transcript - Insider Monkey
Ardelyx Inc Reports Strong Growth Amid Challenges - MSN
Ardelyx First Quarter 2025 Earnings: Misses Expectations - simplywall.st
Ardelyx targets $240M-$250M in IBSRELA 2025 sales amid strong Q1 growth - MSN
Analysts Have Been Trimming Their Ardelyx, Inc. (NASDAQ:ARDX) Price Target After Its Latest Report - Yahoo Finance
Raymond James cuts Ardelyx stock rating, lowers target to $11 By Investing.com - Investing.com Canada
Ardelyx (ARDX) Price Target Lowered by Citigroup to $10.00 | ARDX Stock News - GuruFocus
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Ardelyx, Inc.(ARDX) Shareholders - ACCESS Newswire
Ardelyx (ARDX) Faces Downgrade Amid Revenue Shortfall - GuruFocus
Ardelyx's Q1 Loss Widens; Shares Fall - marketscreener.com
Ardelyx stock downgraded at Raymond James (ARDX:NASDAQ) - Seeking Alpha
Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty (NASDAQ:ARDX) - Seeking Alpha
Stocks in play: SECURE Waste Infrastructure Corp. - The Globe and Mail
Block, Atlassian, Apple, Roku, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Raymond James Downgrades Ardelyx to Outperform From Strong Buy, Adjusts Price Target to $11 From $13 - marketscreener.com
Ardelyx (ARDX) Downgraded by Raymond James Amid Sales Concerns | - GuruFocus
Ardelyx (ARDX) Price Target Reduced by Citi After Q1 Report | AR - GuruFocus
Ardelyx (ARDX) Downgraded by Raymond James Amid Sales Concerns | ARDX Stock News - GuruFocus
Why Twilio Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Ardelyx Inc (ARDX) Q1 2025 Earnings Call Highlights: Robust Revenue Growth Amid Market Challenges - Yahoo
Press Release Distribution & PR Platform - ACCESS Newswire
Shareholders that Lost Money on Ardelyx, Inc. (ARDX) Should Contact Levi & Korsinsky About Pending Class ActionARDX - ACCESS Newswire
Ardelyx (ARDX) Sees Revenue Surge in Q1 2025 - GuruFocus
Ardelyx Inc. Reports Strong Q1 2025 Growth - TipRanks
Ardelyx Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Ardelyx: Q1 Earnings Snapshot - MySA
Ardelyx Inc earnings missed by $0.06, revenue fell short of estimates - Investing.com South Africa
Ardelyx (ARDX) Shares Drop 14% After Q1 Earnings Miss - GuruFocus
Compared to Estimates, Ardelyx (ARDX) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Earnings call transcript: Ardelyx Inc Q1 2025 sees stock drop after earnings miss - Investing.com
Ardelyx (ARDX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Ardelyx falls 14% as Q1 results miss on both lines - MSN
Ardelyx falls 14% as Q1 results miss on both lines (ARDX:NASDAQ) - Seeking Alpha
Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Ardelyx (ARDX) Sees Elevated Options Activity Ahead of Earnings Report | ARDX Stock News - GuruFocus
High Growth Tech Stocks In The US For May 2025 - simplywall.st
Ardelyx appoints new board member, grants equity awards By Investing.com - Investing.com India
Ardelyx appoints new board member, grants equity awards - Investing.com
Ardelyx Appoints Dr. Merdad Parsey to Board - TipRanks
Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors - The Manila Times
Biotech Powerhouse: Ex-Gilead CMO Merdad Parsey Strengthens Ardelyx Board with 25-Year Expertise - Stock Titan
ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Ardelyx Inc (ARDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ardelyx Inc 주식 (ARDX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RAAB MICHAEL | President & CEO |
Apr 04 '25 |
Option Exercise |
0.99 |
20,833 |
20,625 |
1,657,253 |
| RAAB MICHAEL | President & CEO |
Apr 04 '25 |
Sale |
4.59 |
41,666 |
191,151 |
1,615,587 |
0.58%
0.47%
자본화:
|
볼륨(24시간):